The main targets identified for the treatment of glioma are transferrin (Tf), folate, EGFR, vascular endothelial growth factor (VEGF), αvβ3 integrins, matrix metalloproteinases (MMP), and vascular cell adhesion molecule 1 (VCAM-1) [73]. The gene discussed is VCAM1; the disease is central nervous system cancer.